Integrated Investment Consultants’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-313
Closed -$53K 792
2018
Q1
$53K Buy
+313
New +$52.5K 0.02% 419
2017
Q3
$114K Buy
554
+20
+4% +$4.65K 0.05% 269
2017
Q2
$130K Hold
534
0.06% 233
2017
Q1
$128K Sell
534
-149
-22% -$34.7K 0.06% 228
2016
Q4
$143K Buy
683
+30
+5% +$6.21K 0.07% 203
2016
Q3
$152K Buy
653
+61
+10% +$14.9K 0.08% 182
2016
Q2
$137K Buy
592
+154
+35% +$35.5K 0.08% 196
2016
Q1
$103K Buy
+438
New +$125K 0.06% 227

Other funds holding AGN

Integrated Investment Consultants's AGN Position: Q2 2018 in Review

Integrated Investment Consultants sold out of Allergan plc (AGN) in Q2 2018, closing a stake of 313 shares — an estimated $53K sold.

Integrated Investment Consultants first reported a position in AGN in Q1 2016 and held it in 8 quarters. The position peaked at $152K in Q3 2016. 1,044 funds tracked by Wall St. Rank hold AGN as of Q2 2018.

  • Integrated Investment Consultants reported no remaining Allergan plc position as of Q2 2018 after selling out during the quarter.
  • Integrated Investment Consultants sold 313 Allergan plc shares in Q2 2018, an estimated $53K.
  • Integrated Investment Consultants first reported a position in Allergan plc in Q1 2016 and held it in 8 quarters.
  • Integrated Investment Consultants's Allergan plc position peaked at $152K in Q3 2016.
  • 1,044 funds tracked by Wall St. Rank held Allergan plc as of Q2 2018.

Based on Integrated Investment Consultants's 13F filing for Q2 2018, filed 1 Aug 2018.